Русский
Minimally invasive methods of treatment of interstitial cystitis/painful bladder syndrome
DOI: https://dx.doi.org/10.18565/urology.2020.5.93-98
A.G. Martov, N.G. Muzhetskaya, Y.R. Slyukova, R.V. Salyukov
1Department of urology and Andrology of Federal Medical and Biological Center named after A.I. Burnazyan FMBA, Moscow, Russia; 2Urology Department of State Budgetary Health city hospital named after D.D. Pletnev, Moscow, Russia; 3Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology (RSCRR), Moscow, Russia; 4Department of endoscopic urology, Faculty of postgraduate education. Peoples’ Friendship University of Russia, Moscow, Russia; 5Rehabilitation center for persons with disabilities «Preodolenie», Moscow, Russia
Interstitial Cystitis (IC) or Painful Bladder Syndrome (PBS) is a heterogeneous disease which pathogenetic mode development is not fully studied. In the presented literature review IC/PBS is considered as urothelial dysfunction. The main issues discussed relate to IC/PBS diagnosis and minimally invasive methods of its treatment including intravesical instillations of therapeutic agents, botulinum toxin injections into bladder wall and hydrodistension. Efficacy of the above therapeutic methods is far from the desired what gives rise to search novel minimally invasive technologies and protocols to improve the outcomes of traditional treatment methods.
Keywords: painful bladder syndrome, interstitial cystitis, hyaluronic acid, hydrodistension, Hunner lesion
